GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, ...

The La Jolla, California-based biotechnology company said its board approved the reverse split, which will legally take effect at 4:01 p.m. Eastern Time on January 23, 2026. GRI’s common stock is ...